Intra-abdominal Hypertension in Critically Ill Patients

August 24, 2018 updated by: Patrick Murphy, Western University, Canada
The aim of the proposed study is to determine the incidence and prevalence of intra-abdominal hypertension and abdominal compartment syndrome in consecutive intensive care admissions using broad inclusion criteria.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Increased pressure within the abdominal cavity is particularly common in intensive care patients and has been shown to be an independent risk-factor for mortality in this patient population. The quoted rates of intra-abdominal hypertension of range anywhere from 20-60% are dependent on the population of patient studied. The prospective observational studies performed to date have been underpowered, used strict inclusion/exclusion criteria or were performed prior to consensus guidelines on the definition and measurement of intra-abdominal pressure and hypertension.

Study Type

Observational

Enrollment (Anticipated)

286

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • London, Ontario, Canada, N6K 1C2
        • Victoria Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All adults (>18 years of age) admitted to the intensive care unit at Victoria Hospital, London, Ontario who have a Foley catheter in-situ

Description

Inclusion Criteria:

  • Foley catheter in-situ on admission

Exclusion Criteria:

  • Contra-indication to bladder pressure measurement
  • Home service asked that patient is not included
  • Death within 24 priors of admission before bladder pressure measured
  • No bladder pressure performed within 24 hours of admission
  • Consent refused or unable to be obtained (lack of SDM, patient unable to provide)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Elevated Intra-abdominal Pressure
Patients with intra-abdominal pressure > 12 mmHg at any time throughout admission
Normal Intra-abdominal Pressure
Patients with intra-abdominal pressure < 12 mmHg throughout admission

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: While patient in-hospital, expected stay one week on average
As measured prospectively by patient death in the ICU
While patient in-hospital, expected stay one week on average

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay
Time Frame: While patient in-hospital, expected stay one week on average
Measured prospectively from date of admission to ICU to death, or discharge from ICU
While patient in-hospital, expected stay one week on average
Abdominal decompression
Time Frame: While patient in-hospital, expected stay one week on average
Midline laparotomy for abdominal compartment syndrome
While patient in-hospital, expected stay one week on average

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kelly N Vogt, MD, Western University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2015

Primary Completion (Actual)

January 30, 2016

Study Completion (Actual)

May 30, 2016

Study Registration Dates

First Submitted

July 30, 2015

First Submitted That Met QC Criteria

July 30, 2015

First Posted (Estimate)

August 3, 2015

Study Record Updates

Last Update Posted (Actual)

August 27, 2018

Last Update Submitted That Met QC Criteria

August 24, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intra-Abdominal Hypertension

Clinical Trials on No intervention

Subscribe